Indian gov’t, groups face off with drugmaker Novartis in court over patenting cancer drug
September 6, 2011
In a case that could affect India’s role as drug provider to the developing world, the Supreme Court began hearing arguments Tuesday over whether the government had the right to deny a patent to Swiss drugmaker Novartis AG for its lifesaving cancer treatment Gleevec. (Washington Post)
